We demonstrated that aberrantly down‐regulated miR‐449b‐3p targeted ADAM17 to promote NPC metastasis, and ADAM17‐activated NF‐κB could transcriptionally suppress miR‐449b‐3p gene expression in turn. Here, ADAM17 is linked to nasopharyngeal carcinoma.